Last reviewed · How we verify

LEO 90100 aerosol foam — Competitive Intelligence Brief

LEO 90100 aerosol foam (LEO 90100 aerosol foam) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical corticosteroid. Area: Dermatology.

phase 3 Topical corticosteroid Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

LEO 90100 aerosol foam (LEO 90100 aerosol foam) — LEO Pharma. LEO 90100 is a topical corticosteroid aerosol foam formulation designed for enhanced skin penetration and coverage in inflammatory skin conditions.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LEO 90100 aerosol foam TARGET LEO 90100 aerosol foam LEO Pharma phase 3 Topical corticosteroid
Elocon 0.1 % Topical Cream Elocon 0.1 % Topical Cream Jacob Pontoppidan Thyssen marketed Topical corticosteroid (Class III/IV potency) Glucocorticoid receptor
Mometasone Furoate Nasal Irrigation Mometasone Furoate Nasal Irrigation Washington University School of Medicine marketed Topical corticosteroid Glucocorticoid receptor
topical desonide hydrogel 0.05% topical desonide hydrogel 0.05% Wake Forest University marketed Topical corticosteroid (low-to-medium potency) Glucocorticoid receptor
Neo-Synalar Cream Neo-Synalar Cream Noah Rosenberg, MD marketed Topical corticosteroid Glucocorticoid receptor
Fluticasone proprionate 0.05% cream Fluticasone proprionate 0.05% cream Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) marketed Topical corticosteroid Glucocorticoid receptor
Durezol 0.05% Ophthalmic Emulsion Durezol 0.05% Ophthalmic Emulsion Cathleen McCabe MD marketed Topical corticosteroid Glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical corticosteroid class)

  1. LEO Pharma · 3 drugs in this class
  2. Pierre Fabre Medicament · 2 drugs in this class
  3. GlaxoSmithKline · 2 drugs in this class
  4. Promius Pharma, LLC · 2 drugs in this class
  5. Astellas Pharma Inc · 1 drug in this class
  6. Astion Pharma A/S · 1 drug in this class
  7. Al-Azhar University · 1 drug in this class
  8. BUZZZ Pharmaceuticals Limited · 1 drug in this class
  9. Apotex Inc. · 1 drug in this class
  10. Aswan University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LEO 90100 aerosol foam — Competitive Intelligence Brief. https://druglandscape.com/ci/leo-90100-aerosol-foam. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: